 "Sebi gives green signal to two IPOs")
Market regulator Sebi has given nod to the proposed initial public offerings of two companies-- Advanced Enzyme Technologies and Intas Pharmaceuticals.
Advanced Enzyme and Intas Pharmaceuticals had filed their draft red herring prospectus (DRHP) with Sebi in March and June respectively for the proposed public offer.
Sebi issued its final observations on the draft offer documents on September 12, as per the latest update by the market regulator. Sebi's observations are required for companies to launch any public offer.
Also Read
The regulator had received the draft offer documents of Advanced Enzyme on March 28 through its lead manager ICICI Securities, while Sebi got initial papers of Intas Pharmaceuticals on June 14 via merchant banker Kotak Mahindra Capital Company.
Advanced Enzyme, engaged in the research and development, manufacturing and marketing of proprietary enzyme products, proposed to raise Rs 200 crore via IPO.
Healthcare firm Pharmaceuticals is planning to raise Rs 225 crore through fresh issues, while existing shahreholders will also sell shares.
The equity shares would be listed on the BSE and National Stock Exchange.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%